Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.
Steinemann G, Dittmer A, Schmidt J, Josuttis D, Fähling M, Biersack B, Beindorff N, Jolante Koziolek E, Schobert R, Brenner W, Müller T, Nitzsche B, Höpfner M.
Steinemann G, et al. Among authors: dittmer a.
Mol Oncol. 2019 Dec;13(12):2679-2696. doi: 10.1002/1878-0261.12582. Epub 2019 Oct 22.
Mol Oncol. 2019.
PMID: 31583820
Free PMC article.